Optimizing Care for Lower-Risk Myelodysplastic Syndromes: Translating Evidence to Clinical Practice - Episode 1
Understanding Myelodysplastic Syndromes (MDS): Diagnosis, Classification, and Risk Assessment Panelists discuss how myelodysplastic syndromes are diagnosed, classified, and managed, covering prevalence, symptoms, risk stratification tools, prognosis for lower-risk cases, and current treatment challenges.
To start our conversation, how prevalent is MDS? What are common symptoms patients may present with? Can you share how you diagnose and classify MDS?Please comment on common differential diagnoses & tests typically used for MDS diagnosis. Please comment on the risk stratification tools IPSS-M and if you have adapted using this stratification tool in your practice. What do you are share to your patients in terms of prognosis for those with lower-risk MDS? What are some current challenges for treating lower-risk MDS?